143 related articles for article (PubMed ID: 37480810)
1. Intra-racial disaggregation reveals associations between nativity and overall survival in women with endometrial cancer.
Mercadel AJ; Sanchez-Covarrubias AP; Medina HN; Pinheiro PS; Pinto A; George SHL; Schlumbrecht MP
Gynecol Oncol; 2023 Sep; 176():98-105. PubMed ID: 37480810
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in young women with endometrial cancer.
Mukerji B; Baptiste C; Chen L; Tergas AI; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2018 Mar; 148(3):527-534. PubMed ID: 29307452
[TBL] [Abstract][Full Text] [Related]
3. Differences in Cervical Cancer Outcomes by Caribbean Nativity in Black and White Women in Florida.
Jeudin PP; Sanchez-Covarrubias AP; Thiele AR; Reis IM; Kobetz E; George SHL; Schlumbrecht MP
Cancer Control; 2023; 30():10732748231176642. PubMed ID: 37226430
[TBL] [Abstract][Full Text] [Related]
4. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis.
Bregar AJ; Alejandro Rauh-Hain J; Spencer R; Clemmer JT; Schorge JO; Rice LW; Del Carmen MG
Gynecol Oncol; 2017 Apr; 145(1):114-121. PubMed ID: 28159409
[TBL] [Abstract][Full Text] [Related]
5. The association of black race with receipt of hysterectomy and survival in low-risk endometrial cancer.
Taylor KN; Li A; Manuel M; Rimel BJ; Kim KH
Gynecol Oncol; 2023 Aug; 175():156-162. PubMed ID: 37390596
[TBL] [Abstract][Full Text] [Related]
6. Endometrial cancer outcomes among non-Hispanic US born and Caribbean born black women.
Schlumbrecht M; Huang M; Hurley J; George S
Int J Gynecol Cancer; 2019 May; ():. PubMed ID: 31055453
[TBL] [Abstract][Full Text] [Related]
7. Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysis.
Chambers LM; Jia X; Rose PG; AlHilli M
Gynecol Oncol; 2021 Feb; 160(2):405-412. PubMed ID: 33221023
[TBL] [Abstract][Full Text] [Related]
8. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
9. Impact of hospital volume on racial disparities and outcomes for endometrial cancer.
Buskwofie A; Huang Y; Tergas AI; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2018 May; 149(2):329-336. PubMed ID: 29506862
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer.
Lester-Coll NH; Young MR; Park HS; Ratner ES; Litkouhi B; Damast S
Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364
[TBL] [Abstract][Full Text] [Related]
11. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.
Corey L; Cote ML; Ruterbusch JJ; Vezina A; Winer I
Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911
[TBL] [Abstract][Full Text] [Related]
12. Role of adjuvant chemotherapy in patients with FIGO stage IB grade 3 endometrial endometrioid adenocarcinoma treated with surgery and post-operative radiotherapy.
Reshko LB; Gaskins JT; Dryden SM; Metzinger DS; Todd SL; Eldredge-Hindy HB; Silva SR
Int J Gynecol Cancer; 2021 May; 31(5):694-701. PubMed ID: 33741653
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
Cosgrove CM; Cohn DE; Rhoades J; Felix AS
Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer.
Montes de Oca MK; Albright BB; Secord AA; Havrilesky LJ; Moss HA
Int J Gynecol Cancer; 2021 Dec; 31(12):1549-1556. PubMed ID: 34725205
[TBL] [Abstract][Full Text] [Related]
15. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.
Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ
World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193
[TBL] [Abstract][Full Text] [Related]
16. Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer.
Rauh-Hain JA; Hariton E; Clemmer J; Clark RM; Hall T; Boruta DM; Schorge JO; Del Carmen MG
Obstet Gynecol; 2015 Jun; 125(6):1362-1370. PubMed ID: 26000507
[TBL] [Abstract][Full Text] [Related]
17. Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer study.
Felix AS; McLaughlin EM; Caan BJ; Cohn DE; Anderson GL; Paskett ED
Int J Cancer; 2020 Jul; 147(2):404-412. PubMed ID: 31618444
[TBL] [Abstract][Full Text] [Related]
18. The influence of comorbid conditions on racial disparities in endometrial cancer survival.
Ruterbusch JJ; Ali-Fehmi R; Olson SH; Sealy-Jefferson S; Rybicki BA; Hensley-Alford S; Elshaikh MA; Gaba AR; Schultz D; Munkarah AR; Cote ML
Am J Obstet Gynecol; 2014 Dec; 211(6):627.e1-9. PubMed ID: 24954655
[TBL] [Abstract][Full Text] [Related]
19. Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer.
AlHilli MM; Mariani A; Bakkum-Gamez JN; Dowdy SC; Weaver AL; Peethambaram PP; Keeney GL; Cliby WA; Podratz KC
Gynecol Oncol; 2014 Jun; 133(3):485-93. PubMed ID: 24690476
[TBL] [Abstract][Full Text] [Related]
20. Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study.
Ayhan A; Topfedaisi Ozkan N; Öz M; Kimyon Comert G; Firat Cuylan Z; Çoban G; Turkmen O; Erdem B; Şahin H; Akbayır Ö; Dede M; Turan AT; Celik H; Güngör T; Haberal A; Arvas M; Meydanli MM
J Gynecol Oncol; 2018 Jul; 29(4):e48. PubMed ID: 29770619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]